Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India - Patel, Atul; Agarwal, Ritesh; Rudramurthy, Shivaprakash M.; Shevkani, Manoj; Xess, Immaculata; Sharma, Ratna; Savio, Jayanthi; Sethuraman, Nandini; Madan, Surabhi; Shastri, Prakash; Thangaraju, Deepak; Marak, Rungmei; et al. (Emerging infectious diseases, 2021)
Keywords: Antifungal agents; Antifungal Agents - therapeutic use; Bacterial infections; coronavirus disease; Coronaviruses; COVID-19; Diabetes; Disease; Disease transmission; Drug dosages; Epidemics; Epidemiology; Expedited; Fungal infections; Histopathology; Humans; Hypoxemia; India; India - epidemiology; Intensive care; Microscopy; Mortality; Mucormycosis; Mucormycosis - diagnosis; Mucormycosis - drug therapy; Mucormycosis - epidemiology; Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India; Pandemics; Patient outcomes; Patients; respiratory infections; Retrospective Studies; Risk factors; SARS; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Statistics; India; posaconazole; viruses; isavuconazole; SARS; coronavirus; zoonoses; mucormycosis; respiratory infections; India; COVID-19; amphotericin; epidemiology; SARS-CoV-2; fungi; severe acute respiratory syndrome coronavirus 2; coronavirus disease; diabetes